News Room

The 10th session of fourth Board of Directors of Walvax Biotechnology Co., Ltd held on May 29, 2020 reviewed and approved the nomination of Mr. Zhang as Vice President of the Walvax and CEO & President of its subsidiary Shanghai Zerun Biotechnology Co., Ltd.

Mr. Zhang’s biography:

As a seasoned professional executive, Mr. Zhang has been working in biomedical companies and global public health institution for more than three decades. His career has covered across from state-owned enterprise, foreign enterprise, international health institution and private company. His previous positions included the Deputy Managing Director of Shanghai Institute of Biological Products, a subsidiary of China National Biotech Group, General Manager of Haemonetics China Subsidiary, Chief Representative of PATH China office, and Chief Operation Officer of Ustar (Hangzhou) Biotechnology Co., Ltd.

Mr. Zhang owned an MBA from China Europe International Business School (CEIBS) in Shanghai, China, a master of Medical Library and Information Sciences (MLIS) from Dominican University, Illinois, USA, a Bachelor of Arts from Fudan University, Shanghai China, and a diploma in public health issued by Shanghai Municipal Health Bureau.